Evotec SE (EVO) Free Cash Flow (QoQ) (2009 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -99.23% |
| Dec 31, 2025 | 168.10% |
| Sep 30, 2025 | -206.32% |
| Jun 30, 2025 | 463.68% |
| Mar 31, 2025 | -114.98% |
| Dec 31, 2024 | 25.42% |
| Sep 30, 2024 | 566.44% |
| Jun 30, 2024 | -89.37% |
| Mar 31, 2024 | -103.44% |
| Jun 30, 2023 | 436.59% |
| Mar 31, 2023 | -129.66% |
| Dec 31, 2022 | 278.33% |
| Sep 30, 2022 | -137.50% |
| Jun 30, 2022 | 92.26% |
| Mar 31, 2022 | -63.17% |
| Dec 31, 2021 | 4,141.15% |
| Sep 30, 2021 | 78.82% |
| Jun 30, 2021 | -81,262.76% |
| Sep 30, 2010 | 199.41% |
| Jun 30, 2010 | -1,328.31% |